Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the South San Francisco-based genetic testing company filed for Chapter 11 bankruptcy protection.

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Details of th EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation (PDSB) on Wednesday reported a loss of $8.5 million in its first quarter. On a per-share basis, the East Princeton ...

Thierry is also the editor-in-chief of Aviation Week’s ShowNews. Aviation Players Outline 2045 Vision For Air Traffic System is published in Aviation Daily, an Aviation Week Intelligence ...

The business case for equipment purchases is the prime consideration, according to a panel of National Restaurant Association Show Kitchen Innovation judges. “We want to solve for a solution ...